Advanced Accelerator Applications SA
Industry / private company
Location:
Saint-Genis-Pouilly,
France (FR)
ISNI: 0000 0004 0591 5242
[Lu-177]Lu-DOTA-TATE as First-line Therapy for Patients With Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): The NETTER-2 Study (2022)
Singh S, Pavel ME, Kunz PL, De Herder W, Herrmann K, D'Amelio AM, Santoro P, et al.
Conference contribution
LUTATHERA (R) in first line therapy of G2 and G3 GEP-NETs (the NETTER-2 study) (2019)
Ferone D, Pavel ME, Kunz P, De Herder W, Santoro P, Wegener A, Broberg P, et al.
Conference contribution
Relation between objective tumour shrinkage and progression-free survival (PFS) in the NETTER-1 population (2019)
Pavel ME, Broberg P, Caplin M, Ruszniewski P, Strosberg J, Santoro P, Ravasi L, Krenning E
Conference contribution